Liposomal Gold Complex for Melanoma Treatment
Author Information
Author(s): Pinho Jacinta O., Coelho Mariana, Pimpão Catarina, Konwar Jahnobi, Godinho-Santos Ana, Noiva Rute M., Thomas Sophie R., Casini Angela, Soveral Graça, Gaspar Maria Manuela
Primary Institution: Research Institute for Medicines (iMed.ULisboa), Faculty of Pharmacy, Universidade de Lisboa, Portugal
Hypothesis
Can a new organometallic gold complex enhance the treatment of melanoma when formulated in liposomes?
Conclusion
The study demonstrates that the liposomal formulation of the gold-based complex ST004 significantly reduces lung metastases in a murine melanoma model.
Supporting Evidence
- The developed liposomal formulations showed a low mean size (around 100 nm) and high incorporation efficiency (51 ± 15%).
- ST004 formulations exhibited antiproliferative activity with EC50 values in the μmolar range.
- Cell cycle analysis revealed an arrest in G0/G1 phase for Free-ST004 in all cell lines.
- LIP-ST004 led to a G0/G1 halt in B16F10 and to an arrest in S phase in A375 and MNT-1 cells.
- A significant reduction in lung metastases was observed in animals receiving LIP-ST004 compared to free gold complex and DTIC.
Takeaway
Researchers created a special gold medicine that can help fight skin cancer better when it's wrapped in tiny bubbles called liposomes.
Methodology
The study evaluated the antiproliferative activity of the gold complex ST004 in vitro and in vivo using murine melanoma models.
Limitations
Further studies are needed to fully elucidate the mechanisms of action and biodistribution of the gold complex.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website